APA (7th ed.) Citation

García-García, I., Guerra-García, P., Ferreras, C., Borobia, A. M., Carcas, A. J., Queiruga-Parada, J., . . . Pérez-Martínez, A. (2021). A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocol. Trials, 22(1), 1. https://doi.org/10.1186/s13063-021-05625-7

Chicago Style (17th ed.) Citation

García-García, I., et al. "A Phase I/II Dose-escalation Multi-center Study to Evaluate the Safety of Infusion of Natural Killer Cells or Memory T Cells as Adoptive Therapy in Coronavirus Pneumonia And/or Lymphopenia: RELEASE Study Protocol." Trials 22, no. 1 (2021): 1. https://doi.org/10.1186/s13063-021-05625-7.

MLA (9th ed.) Citation

García-García, I., et al. "A Phase I/II Dose-escalation Multi-center Study to Evaluate the Safety of Infusion of Natural Killer Cells or Memory T Cells as Adoptive Therapy in Coronavirus Pneumonia And/or Lymphopenia: RELEASE Study Protocol." Trials, vol. 22, no. 1, 2021, p. 1, https://doi.org/10.1186/s13063-021-05625-7.